It has also been found that SUMOylation mediated by UHRF2 regulates the stability of TCF-4 protein, thereby maintaining the stability of the Wnt/β-catenin signaling pathway, which in turn regulates UHRF2 expression in CRC [62]. This evidence concerns the gene UHRF2 and colorectal carcinoma.